Propylene glycol diacetate
| Common Name: |
Propylene glycol diacetate |
| IUPAC Name: |
2-acetyloxypropyl acetate |
| Molecular Formula: |
C7H12O4 |
| SMILES: |
CC(COC(=O)C)OC(=O)C |
| Inchi: |
1S/C7H12O4/c1-5(11-7(3)9)4-10-6(2)8/h5H,4H2,1-3H3 |
| Inchi Key: |
MLHOXUWWKVQEJB-UHFFFAOYSA-N |
| Cas No: |
623-84-7 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
160.17 |
| Mass (g/mol) |
160.074 |
| Molar Refractivity |
38.33 |
| Net Charge |
|
| HBD |
|
| HBA |
4 |
| Rt Bonds |
5 |
| Rings |
|
| TPSA |
52.60 |
| Hetero Atoms |
4 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
-31 |
| Boiling Point (°C@760.00mm Hg) |
190.00 to 191.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.58 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.71 |
| LogP |
0.501 |
| iLOGP |
2.19 |
| XLOGP3 |
0.73 |
| WLOGP |
0.50 |
| MLOGP |
0.60 |
| ESOL Log S |
-0.96 |
| ESOL Solubility (mg/ml) |
17.4 |
| ESOL Solubility (mol/l) |
0.109 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.41 |
| Ali Solubility (mg/ml) |
6.18 |
| Ali Solubility (mol/l) |
0.04 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-0.86 |
| Silicos-IT Solubility (mg/ml) |
22 |
| Silicos-IT Solubility (mol/l) |
0.14 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
0 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.76 |
| Bioavailability Score |
0.55 |
| Caco2 |
0 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.253 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
0.52 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
